aTyr Pharma reported $11.7M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Ardelyx USD 109.57M 20.96M Mar/2026
aTyr Pharma USD 11.7M 101.49M Mar/2026
Biogen USD 3.92B 918.2M Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Grifols EUR 2.37B 156.97M Dec/2025
Lakefront Biotherapeutics EUR 100.42M 52.44M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
United Therapeutics USD 607.8M 8.7M Jun/2026